Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Venlafaxine Dosing and Safety Considerations for Anxiety

Formulation and Dosing

  • Extended-release (ER) formulation allows for once-daily dosing due to longer elimination half-life 1
  • Blood pressure monitoring is essential, particularly when exceeding 150 mg/day, as venlafaxine can cause dose-dependent increases in blood pressure 1, 2

Discontinuation and Special Considerations

  • Abrupt discontinuation should be avoided; tapering over 10-14 days is recommended to prevent withdrawal symptoms 1, 2
  • Venlafaxine is not recommended for nightmares associated with PTSD based on clinical evidence from the American Academy of Sleep Medicine 3

REFERENCES

1

Target Dose of Venlafaxine for Adults with Depression or Anxiety Disorders [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Dose-Response Relationship and Safety Considerations for Venlafaxine [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018